In models of respiratory infection, vascular inflammation, and ischemic stroke, BRD4 inhibition reduced neutrophil infiltration at the site of injury as measured by immunohistochemical analysis [55,57,76]. This evidence concerns the gene BRD4 and ischemic stroke.